Category : Search result: GLP1 therapies


Generic Semaglutide to Create Rs 50,000 Cr Market

The patent expiry of semaglutide drugs will create a massive Rs 50 billion+ revenue opportunity for generic makers in India and globally over the next 12-15 months, boosting diabetes treatment access. Read the full analysis.

Children's Day 2025: A Look Inside Delhi's Autism Schools

Explore how Higashi Autism School and India Autism Centre provide specialized education, therapies, and vocational training for autistic students in Delhi. Discover their unique approaches to inclusion and skill development.

Apollo Hospitals Q2 Profit Soars 26% on Specialty Care

Apollo Hospitals reports stellar Q2 results with profits surging 26% year-on-year. Discover how their focus on specialty therapies, bed capacity expansion, and robust pharmacy growth is reshaping India's healthcare landscape.

Ancient Healing Therapies Making Modern Comeback

Explore how traditional Indian wellness practices like Marma Chikitsa, sound healing, and Ayurvedic therapies are gaining global recognition as effective alternatives to conventional medicine.

Page 1 of 1